Neoral Related Clinical Trials
Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation [Completed]
Metabolic Pattern of Cyclosporine A and Acute Renal Failure [Completed]
Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? [Completed]
Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels [Active, not recruiting]
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients [Active, not recruiting]
Comparative Study of Modified Release (MR) Tacrolimus/MMF in de Novo Kidney Transplant Recipients [Active, not recruiting]
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients [Active, not recruiting]
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk [Completed]
Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF) [Completed]
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation [Completed]
Comparison Between Clinical and Paraclinical Effect of Iminoral Vs Neoral in Prevention of Acute Rejection in Renal Transplantation [Recruiting]
A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease. [Completed]
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients [Active, not recruiting]
A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients [Recruiting]
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers [Completed]
Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants [Completed]
Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus [Completed]
Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia [Active, not recruiting]
Concentration Controlled Everolimus With Reduced Dose Neoral® Versus Mycophenolate Mofetil With Standard Dose Neoral® in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids [Recruiting]
MD Ezetimibe Cyclosporine Interaction [Completed]
Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients [Completed]
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [Completed]
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris [Active, not recruiting]
Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome [Completed]
Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-Transplant [Active, not recruiting]
Increasing HAART-Induced Immune Restoration With Cyclosporine [Completed]
A Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Ciclosporin/Ciclosporin Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients [Recruiting]
PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients [Completed]
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test [Recruiting]
Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis [Completed]
Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus [Completed]
Everolimus in a Cyclosporine Microemulsion-Free Regimen Compared to a Low-Dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients [Active, not recruiting]
Comparing Therapies for the Treatment of Severe Aplastic Anemia [Active, not recruiting]
Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation [Completed]
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation [Recruiting]
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. [Active, not recruiting]
Efficacy and Safety of a New Multi-Dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms [Recruiting]
Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
Study Evaluating Sirolimus in Kidney Transplant Recipients. [Completed]
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant [Active, not recruiting]
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [Completed]
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms [Recruiting]
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops [Completed]
Cyclosporin Implant to Treat Uveitis [Completed]
Cyclosporine A in the Treatment of JIA Associated Chronic Anterior Uveitis [Completed]
Verification Study of Ciclosporin for Atopic Dermatitis [Completed]
Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus [Completed]
Transitioning From Cyclosporine to Alefacept in Psoriasis [Active, not recruiting]
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil [Recruiting]
Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomain Gland Dysfunction [Recruiting]
Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-Emulsion
Long-Term Study of Ciclosporin for Atopic Dermatitis [Completed]
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis [Recruiting]
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia [Completed]
Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye [Recruiting]
Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome [Recruiting]
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Not yet recruiting]
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis [Recruiting]
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [No longer recruiting]
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [Completed]
Topical Cyclosporine and Disease Progression [Recruiting]
Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Active, not recruiting]
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation [Recruiting]
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer [No longer recruiting]
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients [Recruiting]
Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [No longer recruiting]
Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer [No longer recruiting]
Cyclosporine Microemulsion C2 Monitoring Versus Tacrolimus C0 Monitoring in de Novo Liver Transplant Recipients [No longer recruiting]
Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer [No longer recruiting]
Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma [No longer recruiting]
Peritransplant Cyclosporine in Treating Patients With Hematologic Malignancies Undergoing T-Cell Depleted Allogeneic Stem Cell Transplant Followed By T-Cell Add-Back [No longer recruiting]
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants [Completed]
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy [Recruiting]
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [No longer recruiting]
Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM) [Recruiting]
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients [Active, not recruiting]
Cyclosporine in Treating Patients With T-Cell Large Granular Lymphocyte Leukemia [Recruiting]
Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients [No longer recruiting]
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [No longer recruiting]
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms [Recruiting]
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation [Recruiting]
Study Comparing Cyclosporine With Infliximab in Steroid-Refractory Severe Attacks of Ulcerative Colitis [Recruiting]
Diabetogenicity of Cyclosporine and Tacrolimus [Recruiting]
Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. [No longer recruiting]
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [Completed]
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) [Recruiting]
Combination Chemotherapy and Cyclosporine Followed By Cryotherapy and/or Laser Therapy in Treating Patients With Newly Diagnosed Retinoblastoma in Both Eyes [Recruiting]
Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis [Recruiting]
Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A [Recruiting]
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia [Recruiting]
Effects of Cyclosporine A on Pancreatic Insulin Secretion [Completed]
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus [Recruiting]
Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) [Recruiting]
Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy [Completed]
The Effectiveness of Lower Cyclosporine Doses for Psoriasis [Recruiting]
Efficacy and Safety Study of Everolimus Plus Cyclosporine and Mycophenolic Acid Plus Cyclosporine in Kidney Transplants [Completed]
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants [Recruiting]
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients [Available]
|
